Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of glucose-lowering agents: A population-based community study from the Shizuoka Kokuho database.
Shun KohsakaHiraku KumamaruShiori NishimuraSatoshi ShojiEiji NakataniNao IchiharaHiroyuki YamamotoYoshiki MiyachiHiroaki MiyataPublished in: Journal of diabetes investigation (2021)
The incidence of HHF was similar to that of stroke. A significant portion of our cohort met the inclusion criteria for major randomized clinical trials for SGLT2i, and estimated reduction in the HHF events was substantial.
Keyphrases
- cardiovascular events
- end stage renal disease
- risk factors
- coronary artery disease
- ejection fraction
- cardiovascular disease
- newly diagnosed
- peritoneal dialysis
- atrial fibrillation
- prognostic factors
- type diabetes
- mental health
- emergency department
- metabolic syndrome
- patient reported outcomes
- blood pressure
- clinical trial
- tyrosine kinase
- weight loss
- brain injury
- patient reported
- adipose tissue